Suparma Tbk PT
IDX:SPMA
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
276
390
|
Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one SPMA stock under the Base Case scenario is 627.4 IDR. Compared to the current market price of 304 IDR, Suparma Tbk PT is Undervalued by 52%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Suparma Tbk PT
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for SPMA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Suparma Tbk PT
Balance Sheet Decomposition
Suparma Tbk PT
Current Assets | 1.5T |
Cash & Short-Term Investments | 362.4B |
Receivables | 200B |
Other Current Assets | 907B |
Non-Current Assets | 1.9T |
Long-Term Investments | 30.6B |
PP&E | 1.9T |
Other Non-Current Assets | 15.9B |
Current Liabilities | 524.8B |
Accounts Payable | 111.8B |
Accrued Liabilities | 16.4B |
Short-Term Debt | 77.8B |
Other Current Liabilities | 318.8B |
Non-Current Liabilities | 508B |
Long-Term Debt | 264.8B |
Other Non-Current Liabilities | 243.2B |
Earnings Waterfall
Suparma Tbk PT
Revenue
|
2.6T
IDR
|
Cost of Revenue
|
-2.2T
IDR
|
Gross Profit
|
451.5B
IDR
|
Operating Expenses
|
-211.9B
IDR
|
Operating Income
|
239.5B
IDR
|
Other Expenses
|
-131.3B
IDR
|
Net Income
|
108.3B
IDR
|
Free Cash Flow Analysis
Suparma Tbk PT
IDR | |
Free Cash Flow | IDR |
SPMA Profitability Score
Profitability Due Diligence
Suparma Tbk PT's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
Score
Suparma Tbk PT's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
SPMA Solvency Score
Solvency Due Diligence
Suparma Tbk PT's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Score
Suparma Tbk PT's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SPMA Price Targets Summary
Suparma Tbk PT
Dividends
Current shareholder yield for SPMA is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
PT Suparma Tbk engages in the manufacture and sale of paper and its related products. The company is headquartered in Surabaya, Jawa Timur and currently employs 779 full-time employees. The firm is engaged in the producing of quality paper and packaging paper products, which can be classified into two types: industrial and consumer. Its industrial paper products include duplex board, wrapping kraft, ribbed kraft, laminated kraft, samson kraft, base paper, and machine glazed paper. Its consumer paper products include tissue paper, towel paper, laminated wrapping craft, and laminated machine glazed paper. Its products are marketed under two brand names See-U and Plenty. The firm sells its products domestically and internationally.
Contact
IPO
Employees
Officers
The intrinsic value of one SPMA stock under the Base Case scenario is 627.4 IDR.
Compared to the current market price of 304 IDR, Suparma Tbk PT is Undervalued by 52%.